Rectal indomethacin should be used routinely in all patients for prevention of post-ERCP pancreatitis
- PMID: 28215777
- DOI: 10.1016/j.gie.2016.10.023
Rectal indomethacin should be used routinely in all patients for prevention of post-ERCP pancreatitis
Comment on
-
Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis.Gastrointest Endosc. 2017 Jan;85(1):67-75. doi: 10.1016/j.gie.2016.08.034. Epub 2016 Sep 6. Gastrointest Endosc. 2017. PMID: 27612923
-
Response.Gastrointest Endosc. 2017 Mar;85(3):689-690. doi: 10.1016/j.gie.2016.11.015. Gastrointest Endosc. 2017. PMID: 28215780 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
